RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Low Risk Myelodysplastic Syndromes
Interventions
DRUG

RVU120 (SEL120)

RVU120 will be taken orally every other day (q.o.d). in a 21-day treatment cycle. Doses of RVU120 will be administered from day 1 to day 13 (total of 7 doses per cycle).

Trial Locations (25)

10060

Candiolo Cancer Institute, IRCCS Fondazione del Piemonte per l'Oncologia, Candiolo

24008

Hospital Universitario de León, León

28046

Hospital Universitario La Paz, Madrid

31008

Navarra university clinic, Pamplona

31059

CHU de Toulouse - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse

33604

CHU de Bordeaux - Centre François Magendie - Groupe Hospitalier Sud, Pessac

37007

Complejo Asistencial Universitario de Salamanca, Salamanca

38700

CHU Grenoble Alpes - Hôpital Michallon, Grenoble

40479

Marien Hospital Düsseldorf, Düsseldorf

46010

Hospital Clínico Universitario de Valencia, Valencia

48149

Universitätsklinikum Münster (UKM), Münster

50134

AOU Careggi, Florence

60126

AOU delle Marche, Ancona

70124

AOU Consorziale Policlinico, Università degli Studi Aldo Moro, Bari

75010

Hôpital Saint-Louis, Service d'Hématologie Séniors, Paris

89133

Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria

06202

CHU de Nice - Hôpital l'Archet 1, Nice

04103

Universität Leipzig, Med. Fak., Klinik und Poliklinik für Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie, Leipzig

Unknown

IRCCS Humanitas Research Hospital, Milan

40-027

Samodzielny Publiczny Szpital Kliniczny im.Andrzeja Mielęckiego Śląskiego Uniwersytetu Medycznego w Katowicach, Katowice

40-519

Pratia Hematologia Sp. z o. o. , Pratia Onkologia Katowice, Katowice

93-523

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M.Kopernika w Łodzi, Lodz

02-172

MTZ Clinical Research powered by Pratia, Warsaw

50-367

Uniwersytecki Szpital Kliniczny im.Jana Mikulacza-Radeckiego, Wroclaw

08035

Hematology Department Vall d'Hebron Institute of Oncology (VHIO), Barcelona

All Listed Sponsors
collaborator

Universitätsklinikum Leipzig

OTHER

collaborator

Saint-Louis Hospital, Paris, France

OTHER

collaborator

University of Florence

OTHER

collaborator

University of Salamanca

OTHER

collaborator

Medical University of Warsaw

OTHER

collaborator

Ryvu Therapeutics SA

INDUSTRY

collaborator

European Myelodysplastic Neoplasms Cooperative Group

UNKNOWN

lead

GCP-Service International West GmbH

INDUSTRY

NCT06243458 - RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms | Biotech Hunter | Biotech Hunter